Exelixis' CEO Presents At Morgan Stanley Healthcare Conference (Transcript)

Exelixis, Inc. (EXEL)

Morgan Stanley Healthcare Conference

September 11, 2012 8:35 am ET

Executives

Michael Morrissey - President, Chief Executive Officer

Analysts

Marshall Urist - Morgan Stanley

Presentation

Marshall Urist - Morgan Stanley

Compare to:
Previous Statements by EXEL
» Exelixis' CEO Discusses Q2 2012 Results - Earnings Call Transcript
» Exelixis CEO Presents at Goldman Sachs Healthcare Conference (Transcript)
» Exelixis' Management Presents at Bank of America Merrill Lynch 2012 Health Care Conference (Transcript)
» Exelixis' Management Presents at Deutsche Bank Securities Annual Health Care Conference (Transcript)

So, good morning, everyone. Thanks for joining us. I am Marshall Urist, one of the biotech analysts here at Morgan Stanley and just one piece of business before we get started. Any and all of our research disclosures can be found on any piece of our research or on our website and with that, why don’t we jump in.

We are very happy to be here this morning, with Mike Morrissey, CEO of Exelixis, who I am sure many of you know and before we jump in, this is actually supposed to be open Q&A. So if there any question, please raise your hands and there is microphone circulating.

So with that, Mike, thanks for being here this morning, and maybe to start off, I think it might be useful, you guys just obviously completed a successful and large fundraising. So maybe talk about, give a quick overview for people, where things stand and then we will kind of jump in.

Michael Morrissey

Sounds good. So, again, I will be making forward looking statements this morning. So, please see our SEC filings for a description of the risks that we face in our business. So that’s, right. So we have had a very busy summer and certainly going into a very busy fall.

1 2 3 Next › Last »